Clinical Trial Update: Oral Lactobacillus Rhamnosus TCELL-1 and Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating oral Lactobacillus rhamnosus TCELL-1 as an adjuvant therapy in staged III colorectal cancer patients receiving adj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lactobacillus rhamnosus TCELL-1 (Lactobacillus rhamnosus TCELL-1)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Staged III Colorectal Cancer Receiving Adjuvant Chemotherapy | Phase 2 | Status: UNKNOWN